Small Molecule CMO/CDMO Global Market Report 2025

Small Molecule CMO/CDMO Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on small molecule cmo/cdmo market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for small molecule cmo/cdmo ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The small molecule cmo/cdmo market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Product: Small Molecule Drug Product; Small Molecule API

2) By Stage Type: Clinical; Commercial; Preclinical

3) By Therapeutic Area: Oncology; Neurology; Infectious Disease; Cardiovascular Disease; Respiratory Disorders; Metabolic Disorders; Other Therapeutics

4) By Application: Cardiovascular; Oncology; Diabetes; Immunological Disorders

Subsegments:

1) By Small Molecule Drug Product: Solid Dosage Forms (Tablets, Capsules); Liquid Dosage Forms (Injectables, Solutions); Topical Dosage Forms

2) By Small Molecule API (Active Pharmaceutical Ingredient): Generic APIs; Branded APIs; Custom Synthesis APIs

Companies Mentioned: Patheon NV (Thermo Fisher Scientific); GlaxoSmithKline; Johnson Matthey plc; Lonza Group Ltd.; WuXi AppTec

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.


1. Executive Summary
2. Small Molecule CMO/CDMO Market Characteristics
3. Small Molecule CMO/CDMO Market Trends And Strategies
4. Small Molecule CMO/CDMO Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Small Molecule CMO/CDMO Growth Analysis And Strategic Analysis Framework
5.1. Global Small Molecule CMO/CDMO PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Small Molecule CMO/CDMO Market Growth Rate Analysis
5.4. Global Small Molecule CMO/CDMO Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Small Molecule CMO/CDMO Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Small Molecule CMO/CDMO Total Addressable Market (TAM)
6. Small Molecule CMO/CDMO Market Segmentation
6.1. Global Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Small Molecule Drug Product
Small Molecule API
6.2. Global Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Clinical
Commercial
Preclinical
6.3. Global Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oncology
Neurology
Infectious Disease
Cardiovascular Disease
Respiratory Disorders
Metabolic Disorders
Other Therapeutics
6.4. Global Small Molecule CMO/CDMO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cardiovascular
Oncology
Diabetes
Immunological Disorders
6.5. Global Small Molecule CMO/CDMO Market, Sub-Segmentation Of Small Molecule Drug Product, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Solid Dosage Forms (Tablets, Capsules)
Liquid Dosage Forms (Injectables, Solutions)
Topical Dosage Forms
6.6. Global Small Molecule CMO/CDMO Market, Sub-Segmentation Of Small Molecule API (Active Pharmaceutical Ingredient), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Generic APIs
Branded APIs
Custom Synthesis APIs
7. Small Molecule CMO/CDMO Market Regional And Country Analysis
7.1. Global Small Molecule CMO/CDMO Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Small Molecule CMO/CDMO Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Small Molecule CMO/CDMO Market
8.1. Asia-Pacific Small Molecule CMO/CDMO Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Small Molecule CMO/CDMO Market
9.1. China Small Molecule CMO/CDMO Market Overview
9.2. China Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Small Molecule CMO/CDMO Market
10.1. India Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Small Molecule CMO/CDMO Market
11.1. Japan Small Molecule CMO/CDMO Market Overview
11.2. Japan Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Small Molecule CMO/CDMO Market
12.1. Australia Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Small Molecule CMO/CDMO Market
13.1. Indonesia Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Small Molecule CMO/CDMO Market
14.1. South Korea Small Molecule CMO/CDMO Market Overview
14.2. South Korea Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Small Molecule CMO/CDMO Market
15.1. Western Europe Small Molecule CMO/CDMO Market Overview
15.2. Western Europe Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Small Molecule CMO/CDMO Market
16.1. UK Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Small Molecule CMO/CDMO Market
17.1. Germany Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Small Molecule CMO/CDMO Market
18.1. France Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Small Molecule CMO/CDMO Market
19.1. Italy Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Small Molecule CMO/CDMO Market
20.1. Spain Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Small Molecule CMO/CDMO Market
21.1. Eastern Europe Small Molecule CMO/CDMO Market Overview
21.2. Eastern Europe Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Small Molecule CMO/CDMO Market
22.1. Russia Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Small Molecule CMO/CDMO Market
23.1. North America Small Molecule CMO/CDMO Market Overview
23.2. North America Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Small Molecule CMO/CDMO Market
24.1. USA Small Molecule CMO/CDMO Market Overview
24.2. USA Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Small Molecule CMO/CDMO Market
25.1. Canada Small Molecule CMO/CDMO Market Overview
25.2. Canada Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Small Molecule CMO/CDMO Market
26.1. South America Small Molecule CMO/CDMO Market Overview
26.2. South America Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Small Molecule CMO/CDMO Market
27.1. Brazil Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Small Molecule CMO/CDMO Market
28.1. Middle East Small Molecule CMO/CDMO Market Overview
28.2. Middle East Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Small Molecule CMO/CDMO Market
29.1. Africa Small Molecule CMO/CDMO Market Overview
29.2. Africa Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Small Molecule CMO/CDMO Market Competitive Landscape And Company Profiles
30.1. Small Molecule CMO/CDMO Market Competitive Landscape
30.2. Small Molecule CMO/CDMO Market Company Profiles
30.2.1. Patheon NV (Thermo Fisher Scientific) Overview, Products and Services, Strategy and Financial Analysis
30.2.2. GlaxoSmithKline Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Johnson Matthey plc Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Lonza Group Ltd. Overview, Products and Services, Strategy and Financial Analysis
30.2.5. WuXi AppTec Overview, Products and Services, Strategy and Financial Analysis
31. Small Molecule CMO/CDMO Market Other Major And Innovative Companies
31.1. Catalent Inc.
31.2. Aurobindo Pharma
31.3. Fareva
31.4. Aesica Pharmaceuticals Limited
31.5. Siegfried holdings AG
31.6. Recipharm AB
31.7. Jubilant Life Sciences Limited
31.8. Almac Group
31.9. Piramal Pharma Solutions
31.10. Oxford Chemicals Inc.
31.11. Syngene International Limited
31.12. Novasep
31.13. Pfizer CentreOne
31.14. GVK Biosciences
31.15. ChemPartner
32. Global Small Molecule CMO/CDMO Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Small Molecule CMO/CDMO Market
34. Recent Developments In The Small Molecule CMO/CDMO Market
35. Small Molecule CMO/CDMO Market High Potential Countries, Segments and Strategies
35.1 Small Molecule CMO/CDMO Market In 2029 - Countries Offering Most New Opportunities
35.2 Small Molecule CMO/CDMO Market In 2029 - Segments Offering Most New Opportunities
35.3 Small Molecule CMO/CDMO Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings